Impaired drug metabolism in experimental cirrhosis in the rat

doi:10.1016/0006-2952(78)90330-1

Biochemical Pharmacology

Volume 27, Issue 22, 1978, Pages 2577-2581

https://doi.org/10.1016/0006-2952(78)90330-1 Get rights and content

Abstract

Cirrhosis was produced in the rat by chronic administration of phenobarbital and carbon tetrachloride for 10 weeks. The metabolism of three substrates, aminopyrine. hexobarbital and propranolol, has been investigated in a 9000 g supernatant fraction of liver homogenate and in intact hepatocytes in cirrhotic livers and compared to appropriate phenobarbital-treated controls. In the 9000 g supernatant preparation, the maximal velocity of metabolism for each substrate and the cytochrome P450 concentration were reduced significantly in cirrhotic livers, while total protein and DNA concentration remained unchanged. In intact hepatocytes, the V_maxfor each substrate was reduced, while the apparent K_m remained unchanged. In both in vitro systems, the metabolism of propranolol and of hexobarbital was influenced by cirrhosis to a greater extent than that of aminopyrine. It is concluded that the carbon tetrachloride-phenobarbital model of cirrhosis in the rat is a suitable model in which to study the effects of chronic liver disease on drug disposition.

References (17)

G.R. Wilkinson et al.
Biochem. Pharmac.
(1976)
D.G. Shand et al.
Biochem. Pharmac.
(1971)
O.H. Lowry et al.
J. biol. Chem.
(1951)
T. Omura et al.
J. biol. Chem.
(1964)
R.A. Branch et al.
Clin. Pharmacokinet
(1976)
E.K. McLean et al.
Br. J. exp. Path.
(1969)
W.J. Marshall et al.
Br. J. exp. Path.
(1969)
R.R. Holcomb et al.
J. Pharmac. exp. Ther.
(1974)

There are more references available in the full text version of this article.

Cited by (32)

Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 2. Hemodynamic and drug disposition studies
1996, Hepatology
We assessed hepatic functions and systemic and splanchnic hemodynamics in a new model of hepatic sinusoidal fibrosis. Fibrosis was induced by the simultaneous administration for 8 weeks of diethyl-stilbestrol (DES) (10 mg twice weekly, subcutaneously) and cholesterol-supplemented diet (1%) in rabbits. A marked and progressive impairment of hepatic function was observed during the 8 weeks of treatment with a significant decrease in indocyanine green (ICG) systemic clearance (- 89%; P < .001) and aminopyrine elimination (-69%; P < .001). In fibrotic animals, hyperdynamic circulation was found with an increased cardiac output (+73%, P < 0.01) and a decreased peripheral vascular resistance (-50%; P < .005), as evaluated by the microsphere technique in animals that were awake. The total portal venous inflow was not significantly modified in fibrotic rabbits. However, since there was a marked increase in the liver weight, the portal venous inflow was significantly decreased when expressed per gram of liver weight (-30%; P < .05). In contrast, the hepatic artery blood flow was markedly increased, even when expressed per gram of liver weight (+95%; P < .01). Portal pressure was significantly increased in treated rabbits (from 7.4 +/- .4 to 14.4 +/- .6 mm Hg, P < .01). This new experimental model could prove useful to evaluate the influence of extensive perisinusoidal fibrosis on exchanges between plasma and hepatocytes, particularly of protein-bound substances. (Hepatology 1996 Oct;24(4):865-70)
Metabolism of antipyrine in vivo in two rat models of liver cirrhosis ita relationship to intrinsic clearance in vitro and microsomal membrane lipid composition
1993, Biochemical Pharmacology
Antipyrine metabolism depends on at least three isoenzymes of cytochrome P450 forming the main metabolites 3-OH-, 4-OH- and norantipyrine. We investigated to what extent antipyrine clearance and metabolite formation are impaired in two models of liver cirrhosis in the rat, namely micronodular cirrhosis induced by chronic exposure to phenobarbital/CCl₄ and biliary cirrhosis induced by bile duct ligation. Salivary antipyrine clearance was decreased to a similar extent in cirrhosis induced by CCl₄ and bile duct ligation (−35%). Clearance for production of 3-OH-antipyrine was decreased in both models, while 4-hydroxylation was maintained. Metabolic clearance of both 3-OH-antipyrine and 4-OH-antipyrine in vivo correlated with their clearance in vitro (r = 0.658 and r = 0.583) but not with that of norantipyrine. The microsomal cholesterol content was increased by 16% and 90% in CCl₄ and bile duct-ligated cirrhotic rats (P < 0.001), respectively. Membrane fluidity, expressed as the ratio of phospholipids to cholesterol, correlated with the in vivo clearance for production of norantipyrine (r = 0.841) but not of 3-OH- or 4-OH-antipyrine, while clearance in vitro was not related lipid composition. Our results demonstrate that the cytochrome P450 isoenzymes responsible for the different pathways of antipyrine metabolism are affected to different extents by cirrhosis. Alterations in intrinsic clearance explain only part of the loss of hepatocellular function. Altered lipid composition contributes to this loss of function but other factors, among them loss of hepatocytes and changes in microcirculation, could be more important determinants of the decrease in xenobiotic metabolism in cirrhosis.
Alterations in mitochondrial function and morphology in chronic liver disease: Pathogenesis and potential for therapeutic intervention
1993, Pharmacology and Therapeutics
Studies assessing mitochondrial function and structure in livers from humans or experimental animals with chronic liver disease, including liver cirrhosis, revealed a variety of alterations in comparison with normal subjects or control animals. Depending on the etiology of chronic liver disease, the function of the electron transport chain and/or ATP synthesis was found to be impaired, leading to decreased oxidative metabolism of various substrates and to impaired recovery of the hepatic energy state after a metabolic insult. Changes in mitochondrial structure include megamitochondria with reduced cristae, dilatation of mitochondrial cristae and crystalloid inclusions in the mitochondrial matrix. The most important strategies to maintain an adequate mitochondrial function per liver are mitochondrial proliferation and increases in the activity of critical enzymes or in the content of cofactors per mitochondrion. Possibilities to assess hepatic mitochondrial function and to treat mitochondrial dysfunction in patients with chronic liver disease are discussed.
The effect of malaria infection on 3'-azido-3'-deoxythymidine and paracetamol glucuronidation in rat liver microsomes
1992, Biochemical Pharmacology
Alterations induced by fascioliasis and cirrhosis on the biliary excretion of cefmetazole in wistar rats
1992, Comparative Biochemistry and Physiology. Part C, Comparative
1. Alterations induced by fascioliasis and cirrhosis on the biliary excretion of cefmetazole have been studied in Wistar rats.
2. Both infestation with Fasciola hepatica and experimental cirrhosis originated a significant decrease in the biliary excretion and in bile flow increase induced by the drug.
3. Administration of the β-lactam antibiotic induced a lower degree of uncoupling of biliary lipid secretion in the cirrhotic and fasciolotic animals, but the effect was evident in all experimental groups.
Differential effect of biliary and micronodular cirrhosis on oxidative drug metabolism. In vivo-in vitro correlations of dextromethorphan metabolism in rat models
1991, Biochemical Pharmacology
Oxidative drug metabolism is impaired in liver cirrhosis; it is unclear, however, whether this depends on the etiology of cirrhosis. Therefore, we studied the metabolism of dextromethorphan in two rat models: biliary cirrhosis induced by bile duct ligation and micronodular cirrhosis induced by chronic exposure to CCl₄/phenobarbital. Results were compared with aminopyrine N-demethylation assessed by a breath test in vivo; the latter was reduced to a similar extent in biliary (−41%) and micronodular (−37%) cirrhosis compared to controls. In contrast, clearance of dextromethorphan was significantly (P<0.001) reduced in biliary (25.4±5.3 mL/min/kg) but not in micronodular cirrhosis (48.6±15.6) as compared to controls (62.2±16.2). Intrinsic clearance of dextromethorphan in vitro was reduced by 95% and 63% in biliary and micronodular cirrhosis, respectively (P<0.001 vs controls). It correlated with dextromethorphan clearance in vivo (r = 0.68, P<0.001) whereas correlation with aminopyrine N-demethylation was weak (r=0.42, P<0.05). Our results demonstrate a differential effect of biliary and micronodular cirrhosis on isoenzymes responsible for aminopyrine and dextromethorphan demethylation.

View all citing articles on Scopus

^☆: This work was supported by U.S. Public Health Service Grants GM15431 and RR0095.

^†: Fellow of the Medical Research Council of Canada.

View full text

Impaired drug metabolism in experimental cirrhosis in the rat☆

Abstract

Biochem. Pharmac.

Biochem. Pharmac.

J. biol. Chem.

J. biol. Chem.

Clin. Pharmacokinet

Br. J. exp. Path.

Br. J. exp. Path.

J. Pharmac. exp. Ther.